TipRanks
GeneOne Life Science, Inc. (KR:011000)
:011000
South Korea Market
011000
GeneOne Life Science, Inc.
RESEARCH TOOLSreports

GeneOne Life Science, Inc. (011000) Ratios

― Followers

GeneOne Life Science, Inc. Ratios

KR:011000's free cash flow for Q1 2026 was ₩-0.10. For the 2026 fiscal year, KR:011000's free cash flow was decreased by ₩ and operating cash flow was ₩-0.91. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.46 0.36 0.67 1.51 2.16
Quick Ratio
 0.21 0.11 0.29 0.86 1.72
Cash Ratio
 0.10 0.02 0.03 0.40 0.39
Solvency Ratio
 -0.34 -0.38 -0.47 -1.64 -0.79
Operating Cash Flow Ratio
 -0.29 -0.31 -0.38 -0.95 -0.71
Short-Term Operating Cash Flow Coverage
 -1.69 -1.80 -4.75 -9.04 -1.97
Net Current Asset Value
₩ -55.46B₩ -58.87B₩ -37.09B₩ -4.95B₩ 31.67B
Leverage Ratios
Debt-to-Assets Ratio
 0.26 0.28 0.18 0.11 0.09
Debt-to-Equity Ratio
 0.67 0.81 0.32 0.15 0.11
Debt-to-Capital Ratio
 0.40 0.45 0.24 0.13 0.10
Long-Term Debt-to-Capital Ratio
 0.29 0.33 0.16 0.05 0.00
Financial Leverage Ratio
 2.57 2.91 1.77 1.35 1.23
Debt Service Coverage Ratio
 -2.32 -2.48 -5.14 -17.80 -1.30
Interest Coverage Ratio
 -18.42 -17.87 -19.96 -41.00 -5.48
Debt to Market Cap
 0.63 0.87 0.59 0.04 0.02
Interest Debt Per Share
 2.08K 10.34K 9.21K 235.87 348.13
Net Debt to EBITDA
 -1.10 -1.11 -0.91 -0.13 -0.25
Profitability Margins
Gross Profit Margin
-79.36%-89.53%-30.43%-19.30%19.16%
EBIT Margin
-222.53%-195.55%-130.45%-190.22%-63.11%
EBITDA Margin
-145.76%-119.51%-80.17%-158.44%-51.97%
Operating Profit Margin
-198.24%-177.27%-120.49%-120.31%-82.27%
Pretax Profit Margin
-228.46%-198.80%-136.49%-193.16%-78.11%
Net Profit Margin
-228.82%-199.16%-135.88%-193.44%-78.31%
Continuous Operations Profit Margin
-228.82%-199.16%-135.88%-193.44%-78.31%
Net Income Per EBT
100.16%100.18%99.56%100.15%100.25%
EBT Per EBIT
115.24%112.15%113.28%160.55%94.95%
Return on Assets (ROA)
-31.39%-39.98%-32.07%-51.50%-17.12%
Return on Equity (ROE)
-76.96%-116.54%-56.70%-69.75%-21.02%
Return on Capital Employed (ROCE)
-46.14%-64.86%-39.55%-37.75%-21.20%
Return on Invested Capital (ROIC)
-40.56%-55.99%-37.23%-36.38%-19.73%
Return on Tangible Assets
-31.44%-40.05%-32.11%-51.63%-17.16%
Earnings Yield
-88.86%-142.45%-144.41%-34.91%-6.88%
Efficiency Ratios
Receivables Turnover
 6.68 6.29 4.30 6.07 4.57
Payables Turnover
 1.23 1.79 2.31 4.76 5.26
Inventory Turnover
 2.46 3.38 2.82 3.22 2.65
Fixed Asset Turnover
 0.18 0.25 0.30 0.36 0.34
Asset Turnover
 0.14 0.20 0.24 0.27 0.22
Working Capital Turnover Ratio
 -0.58 -0.99 -33.00 1.58 0.70
Cash Conversion Cycle
 -94.60 -38.08 56.20 96.90 148.17
Days of Sales Outstanding
 54.61 58.04 84.91 60.13 79.85
Days of Inventory Outstanding
 148.26 108.01 129.36 113.37 137.76
Days of Payables Outstanding
 297.48 204.14 158.07 76.60 69.45
Operating Cycle
 202.87 166.06 214.27 173.50 217.61
Cash Flow Ratios
Operating Cash Flow Per Share
 -914.25 -4.84K -5.05K -279.66 -311.19
Free Cash Flow Per Share
 -916.23 -4.84K -6.11K -352.37 -897.21
CapEx Per Share
 1.98 6.97 1.06K 72.71 586.02
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.21 1.26 2.88
Dividend Paid and CapEx Coverage Ratio
 -461.06 -693.55 -4.77 -3.85 -0.53
Capital Expenditure Coverage Ratio
 -461.06 -693.55 -4.77 -3.85 -0.53
Operating Cash Flow Coverage Ratio
 -0.46 -0.50 -0.59 -1.27 -1.23
Operating Cash Flow to Sales Ratio
 -0.88 -0.69 -0.45 -0.54 -0.49
Free Cash Flow Yield
-32.87%-49.45%-57.79%-12.30%-12.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.23 -0.70 -0.69 -2.86 -14.54
Price-to-Sales (P/S) Ratio
 2.69 1.40 0.94 5.54 11.39
Price-to-Book (P/B) Ratio
 0.91 0.82 0.39 2.00 3.06
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.04 -2.02 -1.73 -8.13 -7.98
Price-to-Operating Cash Flow Ratio
 -2.92 -2.03 -2.09 -10.24 -23.01
Price-to-Earnings Growth (PEG) Ratio
 -0.01 0.08 0.02 -0.03 -0.11
Price-to-Fair Value
 0.91 0.82 0.39 2.00 3.06
Enterprise Value Multiple
 -2.94 -2.28 -2.08 -3.62 -22.16
Enterprise Value
 77.27B 65.08B 59.56B 230.80B 561.20B
EV to EBITDA
 -2.94 -2.28 -2.08 -3.62 -22.16
EV to Sales
 4.29 2.72 1.67 5.74 11.52
EV to Free Cash Flow
 -4.86 -3.93 -3.07 -8.42 -8.07
EV to Operating Cash Flow
 -4.87 -3.94 -3.71 -10.61 -23.27
Tangible Book Value Per Share
 2.93K 11.91K 26.87K 1.43K 2.33K
Shareholders’ Equity Per Share
 2.95K 11.97K 26.93K 1.43K 2.34K
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 <0.01 >-0.01 >-0.01
Revenue Per Share
 1.04K 7.01K 11.24K 517.08 628.74
Net Income Per Share
 -2.37K -13.95K -15.27K -1.00K -492.35
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.03 1.02 1.05 1.02 1.24
Research & Development to Revenue
 0.06 0.08 0.10 0.18 0.25
SG&A to Revenue
 0.40 0.32 0.17 0.19 0.15
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 >-0.01
Income Quality
 0.39 0.35 0.33 0.28 0.63
Currency in KRW